First glaucoma review: your doctor looks for optic nerve damage, eye pressure levels, and visual field changes to assess risk and progression. It’s not just one test: careful correlation of OCT, fields, and clinical exam determines whether treatment needs to start, change, or stay stable, says Dr Shibal Bhartiya.
When I see a glaucoma patient for the first time, I am not just checking eye pressure or test reports. I am assessing whether your vision is stable, at risk, orsilently progressing over time.
Glaucoma care is not about a single number or test. It is about understanding long-term risk and protecting vision before damage becomes obvious.
Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.
Clinical Reality (What’s not always obvious)
- A single “normal” test does not rule out glaucoma—early damage can be subtle and fragmented.
- Structure and function don’t always match: OCT may look abnormal before fields change (or vice versa).
- Eye pressure alone is not enough—many patients progress at “normal” pressures.
- The first visit is a baseline, not a conclusion—true clarity often emerges only over follow-up.
- Routine eye exams can miss early glaucoma if risk and progression are not actively assessed.
What You Need To Know
| Aspect | What It Means for You |
|---|---|
| Goal of first visit | Establish baseline risk, not just confirm diagnosis |
| Key things assessed | Optic nerve, eye pressure, visual fields, OCT |
| Why multiple tests | Each test shows a different part of the disease |
| Role of history | Family history, age, systemic factors matter |
| Pressure reading | Important—but not the whole story |
| OCT scan | Detects early structural damage before symptoms |
| Visual field test | Measures functional vision loss |
| Corneal thickness | Helps interpret pressure accurately |
| Angle assessment | Determines glaucoma type and treatment path |
| Big picture | Diagnosis = pattern recognition over time, not a one-time label |
🧠 The Real Frame: Beyond Eye Pressure
Glaucoma is a neurodegenerative disease, not just an eye pressure issue.
By the time vision loss is noticeable, significant damage may already have occurred.
This is why the first consultation is less about “what is your number today” and more about:
- What has already happened
- What might happen next
- Whether your current treatment is enough
🔍 1. Is There Evidence of Progression?
The most important question is:
Is the disease stable, or changing over time?
I look at:
- Visual fields (trend, not just one report)
- OCT scans (nerve fibre layer changes)
- Disc photographs if available
A single normal test does not rule out glaucoma. Progression is often subtle and only visible when patterns are tracked over time.
🔍 2. Do Your Tests Match Your Symptoms?
Many patients say:
- “My reports are normal, but something feels off”
- “Vision feels dull, slow, or tiring”
This matters.
Early glaucoma often shows up as:
- Reduced contrast sensitivity
- Difficulty in low light
- Increased effort while reading
- Navigation discomfort
👉 This is where seeing clearly is not the same as seeing safely.
🔍 3. Is Your Eye Pressure Truly “Controlled”?
Eye pressure is important—but not sufficient.
I assess:
- Baseline pressure vs current levels
- Fluctuations (often missed)
- Target pressure relative to your nerve health
👉 A “normal” pressure may still be too high for your eye.
🔍 4. Are You Overtreated or Undertreated?
More drops do not always mean better care.
I look at:
- Number of medications
- Side effects (dryness, redness, fatigue)
- Adherence (are drops actually being used consistently?)
Sometimes:
- Too many drops → poor compliance
- Too few drops → silent progression
The goal is effective, sustainable treatment, not maximum treatment.
🔍 5. Is There a Missed Diagnosis or Overlap Condition?
Not everything labelled glaucoma behaves like glaucoma.
I actively look for:
- Optic nerve mimics
- Neuro-ophthalmic conditions
- Past misinterpretation of scans
👉 This is especially important in:
- Young patients
- Atypical progression
- “Normal pressure” cases
🔍 6. What Is Your Long-Term Risk?
This is the core of my assessment.
Not:
“How are you today?”
But:
“Where will your vision be in 5–10 years if nothing changes?”
I consider:
- Age
- Rate of progression
- Family history
- Lifestyle and follow-up patterns
👉 Glaucoma damage is often irreversible and obvious only in retrospect.
Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions.
⚠️ Common Misconception
Many patients believe:
“If my reports are okay today, I’m fine.”
In reality:
Glaucoma is a disease of trend, not snapshots.
Normal reports do not guarantee long-term safety.
🧭 What a First Consultation Should Give You
By the end of a proper glaucoma review, you should have clarity on:
- Whether your disease is stable or progressing
- Whether your current treatment is adequate
- What your long-term risk looks like
- What the next step should be
If these are not clear, the consultation is incomplete.
📍To Talk to Dr Bhartiya
If you have been diagnosed with glaucoma, or are unsure whether your current treatment is protecting your vision, a structured first review can help clarify your risk and next steps.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
📍 Gurgaon
📞 +91 88826 38735
🌐 drshibalbhartiya.com
❓ Frequently Asked Questions
Why do I need repeated tests in glaucoma?
Because glaucoma is assessed over time. One report cannot show progression or stability.
Can glaucoma be missed in routine eye exams?
Yes. Many routine exams focus on vision clarity, not optic nerve health or progression.
My eye pressure is normal. Can I still have glaucoma?
Yes. This is called normal-tension glaucoma, where damage occurs despite “normal” readings.
Do I need treatment if I have no symptoms?
Often yes. Glaucoma can progress silently before symptoms appear.
Can I reduce my medications later?
Sometimes, depending on stability, response to treatment, or after procedures like laser or surgery.
About the Author
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.
Access her work on Pubmed, Google Scholar, ResearchGate and ORCID.
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
1500+ Five Star Patient Reviews Google Business Profile
Upload your reports for a structured review.
If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma